Role of MRI radiomics for the prediction of MYCN amplification in neuroblastomas.

[1]  W. Chai,et al.  TP53 Mutation Estimation Based on MRI Radiomics Analysis for Breast Cancer , 2022, Journal of magnetic resonance imaging : JMRI.

[2]  Li Liu,et al.  Radiomics-Based Machine Learning Models for Predicting P504s/P63 Immunohistochemical Expression: A Noninvasive Diagnostic Tool for Prostate Cancer , 2022, Frontiers in Oncology.

[3]  Ji-gang Yang,et al.  Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma , 2022, BMC Medical Imaging.

[4]  S. Saffari,et al.  CT-based morphologic and radiomics features for the classification of MYCN gene amplification status in pediatric neuroblastoma , 2022, Child's Nervous System.

[5]  L. States,et al.  Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN-amplification in neuroblastomas: preliminary results , 2022, European Radiology.

[6]  M. Guckenberger,et al.  Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study , 2022, Physics and imaging in radiation oncology.

[7]  Jixia Li,et al.  Prediction of MYCN Amplification, 1p and 11q Aberrations in Pediatric Neuroblastoma via Pre-therapy 18F-FDG PET/CT Radiomics , 2022, Frontiers in Medicine.

[8]  Matthew A. Zapala,et al.  Incorporating Radiomics into Machine Learning Models to Predict Outcomes of Neuroblastoma , 2022, Journal of Digital Imaging.

[9]  Ji-gang Yang,et al.  Prediction for Mitosis-Karyorrhexis Index Status of Pediatric Neuroblastoma via Machine Learning Based 18F-FDG PET/CT Radiomics , 2022, Diagnostics.

[10]  D. Koh,et al.  Radiomics in Oncology: A Practical Guide , 2021, Radiographics : a review publication of the Radiological Society of North America, Inc.

[11]  I. Koch,et al.  Impact of rescanning and repositioning on radiomic features employing a multi-object phantom in magnetic resonance imaging , 2021, Scientific Reports.

[12]  Huan Liu,et al.  CT-Based Radiomics Signature With Machine Learning Predicts MYCN Amplification in Pediatric Abdominal Neuroblastoma , 2021, Frontiers in Oncology.

[13]  Hannah J. Lee,et al.  Radiomics feature robustness as measured using an MRI phantom , 2021, Scientific Reports.

[14]  P. D. Di Paolo,et al.  Radiogenomics prediction for MYCN amplification in neuroblastoma: A hypothesis generating study , 2021, Pediatric blood & cancer.

[15]  OUP accepted manuscript , 2021, Neuro-Oncology.

[16]  Hui Zheng,et al.  Radiogenomics of neuroblastoma in pediatric patients: CT-based radiomics signature in predicting MYCN amplification , 2020, European Radiology.

[17]  Olivier Saut,et al.  Intensity harmonization techniques influence radiomics features and radiomics-based predictions in sarcoma patients , 2020, Scientific Reports.

[18]  Ellen Poliakoff,et al.  Machine learning algorithm validation with a limited sample size , 2019, PloS one.

[19]  H. Koo,et al.  Clinical significance of MYCN amplification in patients with high‐risk neuroblastoma , 2018, Pediatric blood & cancer.

[20]  G. Brodeur.  Spontaneous regression of neuroblastoma , 2018, Cell and Tissue Research.

[21]  O. Delattre,et al.  Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival , 2017, PloS one.

[22]  M. Arsenian-Henriksson,et al.  The MYCN Protein in Health and Disease , 2017, Genes.

[23]  William A Weiss,et al.  Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.

[24]  J Khan,et al.  International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee , 2009, British Journal of Cancer.

[25]  T. Thompson,et al.  Cancer Incidence Among Children and Adolescents in the United States, 2001–2003 , 2008, Pediatrics.

[26]  B. Hero,et al.  Neuroblastoma , 2007, The Lancet.

[27]  Jayaram K. Udupa,et al.  New variants of a method of MRI scale standardization , 2000, IEEE Transactions on Medical Imaging.